226 related articles for article (PubMed ID: 29671030)
1. Abnormal islet sphingolipid metabolism in type 1 diabetes.
Holm LJ; Krogvold L; Hasselby JP; Kaur S; Claessens LA; Russell MA; Mathews CE; Hanssen KF; Morgan NG; Koeleman BPC; Roep BO; Gerling IC; Pociot F; Dahl-Jørgensen K; Buschard K
Diabetologia; 2018 Jul; 61(7):1650-1661. PubMed ID: 29671030
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate increases very-long-chain sphingolipids and improves blood glucose homeostasis in NOD mice.
Holm LJ; Haupt-Jorgensen M; Giacobini JD; Hasselby JP; Bilgin M; Buschard K
Diabetologia; 2019 Dec; 62(12):2262-2272. PubMed ID: 31410530
[TBL] [Abstract][Full Text] [Related]
3. Treatment with sulfatide or its precursor, galactosylceramide, prevents diabetes in NOD mice.
Buschard K; Hanspers K; Fredman P; Reich EP
Autoimmunity; 2001; 34(1):9-17. PubMed ID: 11681495
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice.
Akazawa S; Mackin L; Jhala G; Fynch S; Catterall T; Selck C; Graham KL; Krishnamurthy B; Pappas EG; Kwong CJ; Sutherland APR; Kay TWH; Brodnicki TC; Thomas HE
Diabetologia; 2021 Apr; 64(4):878-889. PubMed ID: 33483762
[TBL] [Abstract][Full Text] [Related]
5. Influence of sphingolipid enzymes on blood glucose levels, development of diabetes, and involvement of pericytes.
Buschard K; Josefsen K; Krogvold L; Gerling I; Dahl-Jørgensen K; Pociot F
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3792. PubMed ID: 38517704
[TBL] [Abstract][Full Text] [Related]
6. Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine.
Pöysti S; Silojärvi S; Brodnicki TC; Catterall T; Liu X; Mackin L; Luster AD; Kay TWH; Christen U; Thomas HE; Hänninen A
J Autoimmun; 2023 Nov; 140():103090. PubMed ID: 37572540
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice.
Mukherjee G; Chaparro RJ; Schloss J; Smith C; Bando CD; DiLorenzo TP
Immunology; 2015 Apr; 144(4):631-40. PubMed ID: 25333865
[TBL] [Abstract][Full Text] [Related]
8. Type 1 diabetes pathogenesis is modulated by spontaneous autoimmune responses to endogenous retrovirus antigens in NOD mice.
Bashratyan R; Regn D; Rahman MJ; Marquardt K; Fink E; Hu WY; Elder JH; Binley J; Sherman LA; Dai YD
Eur J Immunol; 2017 Mar; 47(3):575-584. PubMed ID: 28083937
[TBL] [Abstract][Full Text] [Related]
9. Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis.
Fox CJ; Paterson AD; Mortin-Toth SM; Danska JS
Am J Hum Genet; 2000 Jul; 67(1):67-81. PubMed ID: 10848492
[TBL] [Abstract][Full Text] [Related]
10. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
Chosich N; Harrison LC
Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
[TBL] [Abstract][Full Text] [Related]
11. Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.
Mathews CE; Graser RT; Savinov A; Serreze DV; Leiter EH
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):235-40. PubMed ID: 11136257
[TBL] [Abstract][Full Text] [Related]
12. Administration of sulfatide to ameliorate type I diabetes in non-obese diabetic mice.
Rhost S; Lofbom L; Mansson J-; Lehuen A; Blomqvist M; Cardell SL
Scand J Immunol; 2014 Apr; 79(4):260-6. PubMed ID: 24795987
[TBL] [Abstract][Full Text] [Related]
13. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
Redd S; Ginn S; Ross JM
Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
15. Selective lack of the C16:0 fatty acid isoform of sulfatide in pancreas of type II diabetic animal models.
Blomqvist M; Osterbye T; Månsson JE; Horn T; Buschard K; Fredman P
APMIS; 2003 Sep; 111(9):867-77. PubMed ID: 14510644
[TBL] [Abstract][Full Text] [Related]
16. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells.
Yoon JW; Yoon CS; Lim HW; Huang QQ; Kang Y; Pyun KH; Hirasawa K; Sherwin RS; Jun HS
Science; 1999 May; 284(5417):1183-7. PubMed ID: 10325232
[TBL] [Abstract][Full Text] [Related]
17. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
18. Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice.
Carrero JA; McCarthy DP; Ferris ST; Wan X; Hu H; Zinselmeyer BH; Vomund AN; Unanue ER
Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10418-E10427. PubMed ID: 29133420
[TBL] [Abstract][Full Text] [Related]
19. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.
Chen MC; Proost P; Gysemans C; Mathieu C; Eizirik DL
Diabetologia; 2001 Mar; 44(3):325-32. PubMed ID: 11317664
[TBL] [Abstract][Full Text] [Related]
20. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
